PHARMANAUS
ActivePHARMANAUS has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €633k and a net result of €-11k. Equity remains stable across the filed fiscal years (±1.1% per year). Its solvency ranks better than 67% of 18173 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
54
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability18▼-1
Solvency79=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 2.17 against 2.16 in 2024; short-term debt: 45.1% and cash: 3.8% of total assets), and 46.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-06-2026, 49 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
49 d early
2024
125 d early
2023
47 d early
2022
94 d early
2021
31 d early
2020
107 d early
2019
10 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-11k▼ 56.5%
2024 · €-7k
2018: €33k
2019: €25k
2020: €29k
2021: €128k
2022: €385
2023: €3k
2024: €-7k
2018 → 2025
Working capital
€622k▼ 0.1%
2024 · €623k
2018: €-441k
2019: €-451k
2020: €-471k
2021: €820k
2022: €649k
2023: €636k
2024: €623k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€745k-€649k▼ 12.8%€651k▲ 0.3%€644k▼ 1.1%€633k▼ 1.7%
Operating result€208k-€11k▼ 94.7%€17k▲ 52.2%€-9k€-13k▼ 45.0%
Net result€128k-€385▼ 99.7%€3k▲ 584%€-7k€-11k▼ 56.5%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €13k in 2025 against €9k in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.18M
Fixed assets
€24k▼ 29.1%
Current assets
€1.15M▼ 0.4%
Equity and liabilities €1.18M
Equity
€633k▼ 1.7%
Debt
€545k▼ 0.6%
The debt ratio rises from 46.0% to 46.3%. Equity and debt are lower.
Key figures and ratios
EBITDA
€-3k▼
2024 · €2k
Cash flow
€-912▼
2024 · €5k
Solvency
53.7%▼
2024 · 54.0%
Current ratio
2.17▲
2024 · 2.16
Quick ratio
2.17▲
2024 · 2.16
Debt / equity
0.86▲
2024 · 0.85
ROE
-1.7%▼
2024 · -1.1%
ROA
-0.9%▼
2024 · -0.6%
Interest coverage
-0.23▼
2024 · 0.15
Debt
€545k▼
2024 · €548k
Debt ≤ 1 year
€532k▼
2024 · €535k
Income taxes
€500▼
2024 · €842
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.19M€1.18M▼
Fixed assets21/28€34k€24k▼
Tangible fixed assets22/27€34k€24k▼
Furniture and vehicles24€34k€24k▼
Current assets29/58€1.16M€1.15M▼
Amounts receivable within one year40/41€6k€7k▲
Trade receivables40€6k€6k=
Other amounts receivable41-€1k
Current investments50/53€1.08M€1.10M▲
Cash at bank and in hand54/58€67k€45k▼
Deferred charges and accrued income490/1€999€1k▲
Equity and liabilities
Total equity and liabilities10/49€1.19M€1.18M▼
Equity10/15€644k€633k▼
Contributions10/11€389k€389k=
Reserves13€255k€244k▼
Distributable reserves133€255k€244k▼
Profit (loss) carried forward14€220€335▲
Amounts payable17/49€548k€545k▼
Amounts payable within one year42/48€535k€532k▼
Trade debts44€1k€1k▲
Suppliers440/4€1k€1k▲
Taxes, remuneration and social security45€4k€2k▼
Taxes450/3€4k€2k▼
Other amounts payable47/48€529k€528k▼
Accrued charges and deferred income492/3€13k€13k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€10k▼
Other operating charges640/8€868€760▼
Gross operating margin9900€3k€-3k▼
Operating profit (loss)9901€-9k€-13k▼
Financial income75/76B€18k€18k▲
Recurring financial income75€18k€18k▲
Financial charges65/66B€15k€15k▲
Recurring financial charges65€15k€15k▲
Profit (loss) for the period before taxes9903€-6k€-10k▼
Income taxes67/77€842€500▼
Profit (loss) for the period9904€-7k€-11k▼
Profit (loss) for the period to be appropriated9905€-7k€-11k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-7k€-11k▼
Profit (loss) brought forward from the previous period14P€176€220▲
Transfer from equity791/2€7k€11k▲
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €-11k
Net result drops to €-11k, the lowest in the series.
28-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
14-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
28-04
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Highest result since 2018net €128k ▲345%
Operating result €208k, net result €128k, both a record.
31-12
Financial
Liquidity times 22current ratio 2.52
Current ratio from 0.11 to 2.52.
15-04
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
10-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 10 days late
2019
29-04
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
03-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
21-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Herve · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue des deux Tilleuls 444652 HerveGround area
1,364 m²
Building footprint
184 m²
Volume, LiDAR
1,419 m³
2 parcels, Wallonia · tallest building 11.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
P.S.P.M.E.
since 20042.137.643.834
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63085A0129/00M000 | Wallonia | 1,172 m² | 1 · 112 m² | 8.2 m · 2 fl. |
| 62032C0664/00E006 | Wallonia | 192 m² | 1 · 72 m² | 11.1 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteEsneux2.137.643.834
Similar companies · same sector, comparable size
DIERICK & VERLEYEN MOUSCRON
BE 0825.736.056
Mouscron · Eq €633k
APOTHEEK BOLLEN ELS
BE 0822.270.186
Genk · Eq €633k
PHARMACIE BOLLY A SAINT-GEORGES
BE 0887.822.984
Saint-Georges-sur-Meuse · Eq €633k
PHARMACIE MERCADIER
BE 0649.463.696
Waterloo · Eq €633k
Apotheek P. Hostens
BE 0406.780.386
Antwerpen · Eq €634k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,267 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded27-06-2001
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles
52320
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.